Viking Therapeutics, Inc. (VKTX) Operating Lease, Liability USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Viking Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2024.
  • Viking Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $1.18 M, a 20.7% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.18 M -$309 K -20.7% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $1.26 M -$304 K -19.4% Dec 31, 2023 10-Q 2024-04-25
Q3 2023 $1.34 M -$299 K -18.3% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.41 M -$238 K -14.4% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 $1.49 M Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $1.56 M +$1.54 M +5293% Dec 31, 2022 10-K 2024-02-07
Q3 2022 $1.64 M +$1.52 M +1323% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $1.65 M +$1.45 M +734% Jun 30, 2022 10-Q 2022-07-27
Q4 2021 $29 K -$330 K -91.9% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $115 K -$323 K -73.7% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $198 K -$316 K -61.5% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $279 K -$309 K -52.6% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $359 K -$303 K -45.8% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $438 K -$295 K -40.2% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $514 K -$287 K -35.8% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $588 K -$281 K -32.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $662 K Dec 31, 2019 10-K 2021-02-17
Q3 2019 $733 K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $801 K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $869 K Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.